-
AI Drug Repurposing Tool Offers Suggestions Based on Disease Networks
Nov 20 | Clinical Research News | arvard scientists, led by Dr. Marinka Zitnik, have developed an AI-based tool, TxGNN, to identify drug repurposing opportunities for diseases lacking effective treatments. The AI model harnesses a novel approach by focusing on multiple diseases simultaneously, allowing insights from well-documented conditions to be applied to rare diseases with sparse data. More -
Pharma Leaders Tackle Persistent Quality Challenges and the Future of Clinical Trials
Nov 19 | Clinical Research News | Pharma leaders took on clinical trial quality in a panel discussion at the SCOPE Europe conference last month in Barcelona. While technologies change, the conversation underscored a central truth: the push for quality in clinical research remains as vital, yet as challenging, as ever. More -
The Case for Integrating Placental Pathology into Prospective Clinical Trials
Nov 14 | Clinical Research News | Perinatal pathologists are calling for placental pathology to be incorporated into prospective clinical trials so they can start telling clinical providers what the findings in their reports mean. For want of funding and the relevant diagnostic expertise, the placenta has long been a woefully under-investigated organ that could be providing critical insights on pregnancy-related conditions like preeclampsia and preterm birth that are currently defined solely based on a clinical diagnosis. More -
AI Regulation Sparks Debate at Scope Europe Conference: Industry Leaders Weigh In
Nov 12 | Clinical Research News | Last week at SCOPE Europe, industry leaders took on the impact of AI regulation—particularly the European Union's AI Act—on the clinical research and life sciences sectors. Moderated by BioSpace’s Lori Ellis, the panelists included Firas Abdessalem of Sanofi, Christopher Hart of Foley Hoag, Ricardo Gaminha Pacheco of InSilico Medicine, and Artemy Shumskiy of Latvian VC company LongeVC. Together they discussed how the EU’s AI Act is likely to impact innovation, funding, and partnerships in the life sciences. More -
Ensuring Study Participant Adherence: Strategies for Successful Remote Data Collection in Clinical Trials Using Wearable Technologies
Nov 08 | Clinical Research News | Ensuring clinical trial participants adhere to study protocols is essential for reliable clinical trial results. If participants aren't consistent with their participation, the data collected won't accurately reflect the effectiveness of a treatment or therapy. Poor adherence can slow down or even derail clinical breakthroughs. More -
Scope of Things: SCOPE Europe 2024, AI in Clinical Trials, Rising Stars, More
Nov 07 | Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz gives you the latest news on a study for AI system for drug repurposing, a window trial for a new triple-negative breast cancer treatment, Jill Pellegrino’s transition from CVS to AutoCruitment, publication bias with industry sponsored studies for psychiatric drugs, and more. More -
What Will It Take—And What Does It Look Like—For Clinical Care and Clinical Research To Converge?
Nov 04 | Clinical Research News | A profound shift is underway: one that positions patients not merely as recipients of clinical care but as active participants and collaborators in clinical research. A panel at last week’s SCOPE Summit Europe took on this challenge. More -
SCOPE Europe 2024 Announces Best of Show Winners
Oct 30 | Clinical Research News | Clinical Research News and ClinEco announced three Best of Show winners today at the 2024 SCOPE Europe conference in Barcelona, Spain. The winning companies that submitted their products include Anju Software, Greenphire, and Medidata. More -
IQVIA Introduces New AI Assistant, DHL Express, Thermo Fisher Partnership, Novel Cellular Blood Pressure Monitor, More
Oct 30 | Clinical Research News | IQVIA introduces IQVIA AI Assistant; DHL Express and Thermo Fisher Scientific join forces to drive more sustainable clinical research services; Withings Health Solutions announces a first-of-its-kind cellular blood pressure monitor; and more. More -
Follow the Money: Trials for Major Depressive Disorder Therapies, Kidney Disease Treatment, More
Oct 29 | Clinical Research News | Seaport Therapeutics plans to advance their therapeutic candidate SPT-300, an oral prodrug of allopregnanolone; Purespring Therapeutics will initiate a clinical trial for IgAN, a common, chronic kidney disease primarily affecting young adults; and more. More
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.
